C.E. Barber, MD, FRCPC, PhD, Assistant Professor, D.A. Marshall, PhD, Professor, C. Barnabe, MD, FRCPC, MSc, Associate Professor, G.S. Hazlewood, MD, FRCPC, PhD, Associate Professor, Department of Medicine, Department of Community Health Sciences Cumming School of Medicine, University of Calgary, Calgary, Alberta, and Arthritis Research Canada;
K.L. Then, ACNP, CCN(C), PhD, Professor, M. Hall, MSc, CCRP, Research Associate, J.A. Rankin, ACNP, PhD, Professor, Faculty of Nursing, University of Calgary, Calgary, Alberta.
J Rheumatol. 2021 Mar;48(3):326-334. doi: 10.3899/jrheum.200688. Epub 2020 Sep 1.
The aim of this study was to develop a patient-centered quality measurement framework to address a predefined vision statement and 7 strategic objectives for rheumatoid arthritis (RA) care that was developed in prior qualitative work with arthritis stakeholders.
One hundred forty-seven RA-related performance measures (PMs) were identified from a systematic review. A candidate list of 26 PMs meeting predefined criteria and addressing the strategic objectives previously defined was then assessed during a 3-round (R) modified Delphi. Seventeen panelists with expertise in RA, quality measurement, and/or lived experience with RA rated each PM on a 1-9 scale based on the items of importance, feasibility, and priority for inclusion in the framework during R1 and R3, with a moderated discussion in R2. PMs with median scores ≥ 7 on all 3 items without disagreement were included in the final set, which then underwent public comment.
Twenty-one measures were included in the final framework (15 PMs from the Delphi and 6 published system-level measures on access to care and treatment). The measures included 4 addressing early access to care and timely diagnosis, 12 evidence-based care for RA and related comorbidities, 1 addressing patient participation as an informed partner in care, and 4 on patient outcomes.
The proposed framework builds upon existing measures capturing early access to care and treatment in RA and adds important PMs to promote high-quality RA care and outcome measurement. In the next phase, the authors will test the framework in clinical practice in addition to addressing certain areas where no suitable PMs were identified.
本研究旨在制定一个以患者为中心的质量衡量框架,以解决先前与关节炎利益相关者进行的定性工作中制定的类风湿关节炎(RA)护理的既定愿景声明和 7 项战略目标。
从系统评价中确定了 147 项与 RA 相关的绩效衡量指标(PM)。然后,在三轮(R)修改后的 Delphi 中,对符合预定标准且针对先前定义的战略目标的 26 项 PM 候选名单进行评估。17 名具有 RA 专业知识、质量衡量和/或 RA 生活经验的专家组成的小组根据重要性、可行性和纳入框架的优先级,对每个 PM 进行 1-9 分的评分在 R1 和 R3 期间,在 R2 期间进行了 moderation 讨论。在所有 3 项指标上中位数得分≥7,且无分歧的 PM 将纳入最终集合,然后进行公开评论。
最终框架纳入了 21 项措施(德尔福的 15 项 PM 和 6 项关于获得护理和治疗的已发表系统级措施)。这些措施包括 4 项旨在早期获得护理和及时诊断,12 项针对 RA 及相关合并症的循证护理,1 项旨在促进患者作为知情护理伙伴的参与,以及 4 项针对患者结局的措施。
拟议的框架建立在现有的衡量 RA 早期获得护理和治疗的措施基础上,并增加了重要的 PM,以促进高质量的 RA 护理和结果衡量。在下一阶段,作者将除了解决某些没有合适 PM 的领域外,还将在临床实践中测试该框架。